SOKA YU: Open Payments
NPI 1073989869 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,619 in 64 payments from 10 companies in 2025. Trend: 2023 $1,487 · 2024 $1,639 · 2025 $3,619
Food & beverage: $2,360Travel & lodging: $1,260
| Company | Payments | Amount |
|---|---|---|
| LivaNova USA, Inc. | 7 | $1,705 |
| UCB, Inc. | 11 | $590 |
| Neurelis, Inc. | 23 | $372 |
| Neurocrine BioSciences, Inc. | 2 | $347 |
| SK Life Science, Inc. | 15 | $315 |
| MDD US Operations, LLC | 1 | $144 |
| JAZZ PHARMACEUTICALS INC. | 2 | $51 |
| Integra LifeSciences Corporation | 1 | $48 |
| Aucta Pharmaceuticals, Inc. | 1 | $28 |
| ACADIA Pharmaceuticals Inc | 1 | $18 |
Products named: VNS Therapy, Fintepla, VALTOCO, INGREZZA, Nayzilam, Briviact, EPIDIOLEX, CODMAN CERTAS.
Industry payments across NY — which companies pay providers there.
